Patients with retinal diseases who were treated with anti-VEGF therapies through manufacturer patient assistance programs ...

Regeneron Pharmaceuticals, Inc. nears a key earnings report after a strong JPM Healthcare update. Click here to find out why ...

AbbVie extended the patent life on Humira for years, enough time to more than replace the sales. Now Merck and Bristol Myers ...

Researchers at the University of Twente and Radboudumc are developing a promising new model to enhance understanding of the ...

The Central Drugs Standard Control Organisation (CDSCO) has granted multiple CT-18 approvals between January 2020 and ...

Perioperative prostaglandin analog use is not associated with increased risk for pseudophakic cystoid macular edema after cataract surgery.

India's drug regulator, the Central Drugs Standard Control Organisation (CDSCO), has approved a wide range of recombinant DNA (r-DNA)-origin drugs and biologics for manufacture ...

The panel discussion, “Innovations in Breast Cancer Treatment,” examined the challenge of maintaining or increasing access to care as breast cancer treatment becomes more stratified through biomarker ...

Type 1 diabetes is a chronic autoimmune condition affecting over 9 million people worldwide, caused by the body's immune ...

Sarepta’s three-year Elevidys win follows a challenging 2025 for the company, which was contending with safety concerns around Elevidys. Cassandra Klos/Bloomberg via Getty Images. Following a tough ...